Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
PLoS One ; 16(3): e0246314, 2021.
Article En | MEDLINE | ID: mdl-33739987

During the last months of the coronavirus pandemic, with all those public restrictions and health interventions, the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appears now to have been raised in some countries around the world. Iran was one of those first countries facing the second wave of coronavirus, due to the lack of appropriate public restrictions because of economic problems the country is facing. The clinical and demographic characteristics of severe cases and non-severe cases of Coronavirus Disease (COVID-19) in 192 patients in Tehran, Iran, between June 16 and July 11, 2020, were investigated. The patients were divided into severe cases (n = 82) and non-severe cases (n = 110). Demographic and clinical characteristics were compared between the two study clusters. The mean age was 54.6 ± 17.2 years, and the most common presenting symptom was persistent cough (81.8%) and fever (79.7%). The logistic regression model revealed that age, BMI, and affected family members were statistically associated with severity. Patients with complicated conditions of disorders faced more hospitalization days and medical care than the average statistical data. As the coronavirus spike in the case and death reports from June 2020, we observed the rise in the incidence of severe cases, where 42.7% (82/192) of cases have resulted in severe conditions. Our findings also suggested that the effect of IFB (Betamethasone) was more valid than the other alternative drugs such as LPV/r and IVIg.


COVID-19/pathology , Adult , Aged , Betamethasone/therapeutic use , Body Mass Index , COVID-19/epidemiology , COVID-19/virology , Cough/etiology , Female , Fever/etiology , Humans , Immunoglobulins, Intravenous/therapeutic use , Iran/epidemiology , Logistic Models , Male , Middle Aged , Pandemics , Retrospective Studies , SARS-CoV-2/isolation & purification , Severity of Illness Index , COVID-19 Drug Treatment
2.
World Neurosurg ; 117: 413-418, 2018 Sep.
Article En | MEDLINE | ID: mdl-30157597

BACKGROUND: Central nervous system tuberculoma is the most severe manifestation of extrapulmonary tuberculosis with high mortality. Cavernous sinus tuberculoma (CST) is a very rare central nervous system tuberculoma with few cases reported in the literature. CASE DESCRIPTION: A 57-year-old woman was admitted to our clinic with acute diplopia and headache limited to the right side. There was no specific medical history except for migraine, depression, and anxiety, all of which were controlled by oral medications. Physical examination revealed ptosis and mydriasis in the right eye, which indicated right third and sixth cranial nerve palsies. Pituitary magnetic resonance imaging showed a right parasellar lesion at the cavernous sinus wall and ophthalmic nerve. Laboratory examinations and brain computed tomography scan showed negative findings. Initial differential diagnosis included meningioma, sarcoidosis, tuberculoma, and lymphoma. However, results of further studies, including blood and cerebrospinal fluid cultures and Mycobacterium tuberculosis DNA assay, were negative. Biopsy of the cerebral lesion was performed through the subfrontal approach, and histopathologic study confirmed CST. She was treated with a standard antituberculous regimen. After 12 months of follow-up, no cerebral or clinical findings were seen. CONCLUSIONS: CST is a rare presentation of M. tuberculosis, and the diagnosis is a difficult challenge. However, accurate diagnosis and timely treatment of CST can result in complete cure.


Abducens Nerve Diseases/etiology , Cavernous Sinus , Oculomotor Nerve Diseases/etiology , Tuberculoma, Intracranial/complications , Tuberculoma, Intracranial/diagnosis , Abducens Nerve Diseases/diagnosis , Abducens Nerve Diseases/pathology , Abducens Nerve Diseases/therapy , Diagnosis, Differential , Female , Humans , Middle Aged , Oculomotor Nerve Diseases/diagnosis , Oculomotor Nerve Diseases/pathology , Oculomotor Nerve Diseases/therapy , Tuberculoma, Intracranial/pathology , Tuberculoma, Intracranial/therapy
...